MTM(SH:688029) Xin Lang Cai Jing·2026-01-26 02:29Group 1 - The core point of the news is that Nanwei Medical experienced a decline of 5.04% in its stock price, reaching 81.18 yuan per share, with a trading volume of 112 million yuan and a turnover rate of 0.72%, resulting in a total market capitalization of 15.249 billion yuan [1] - Nanwei Medical Technology Co., Ltd. is located in Jiangbei New District, Nanjing, Jiangsu Province, and was established on May 10, 2000, with its listing date on July 22, 2019. The company's main business involves the research, development, manufacturing, and sales of minimally invasive medical devices [1] - The revenue composition of Nanwei Medical is as follows: endoscopic consumables account for 77.80%, other categories 13.17%, tumor intervention 7.28%, visualization 1.00%, and other (supplementary) 0.74% [1] Group 2 - From the perspective of the top ten circulating shareholders of Nanwei Medical, Huabao Fund has one fund among them. The Huabao CSI Medical ETF (512170) reduced its holdings by 459,000 shares in the third quarter, holding a total of 3.2232 million shares, which represents 1.72% of the circulating shares. The estimated floating loss today is approximately 13.8921 million yuan [2] - The Huabao CSI Medical ETF (512170) was established on May 20, 2019, with a latest scale of 25.263 billion yuan. Year-to-date returns are 9.07%, ranking 2041 out of 5579 in its category; the one-year return is 19.46%, ranking 3487 out of 4270; and since inception, the return is 11.04% [2]